East Hampton, NY, January 09, 2014 --(PR.com
)-- Dilmax Corp. (OTCQB: DMAX) (the “Company”) an innovative emotional wellness and lifestyle company focusing on helping people help themselves through its unique and proprietary “living breath” processes and products, training, and education, today announced that, effective immediately, it has changed its name to Drug Free Solution, Inc. to better reflect the Company’s line of services and products and to support its short and long-term goals. In addition, the Company effectuated a forward stock-split of its common stock on a basis of three for one. The Company’s common stock will trade under the symbol “DMAXD” for twenty business days and thereafter the Company’s new symbol “DSOL” will take effect.
Genie O’Malley, the Company’s CEO, stated, "I believe that the new name better signifies the Company’s purpose and products – an integrated and proprietary breathing technique pioneered by O’Malley to provide consumers and communities with emotional wellness through at-home programs."
The Company launched its trial phase of consumer products in May 2013 under the product name of Living Breath Project. The company anticipates a first quarter 2014 launch of a range of home products that are aimed at healing heroin/opiate and methamphetamine addiction, as well as various emotional conditions. Drug Free Solution’s products are positioned to become the leading answer to the world’s drug epidemic. Offering low-cost and easy-to-practice programs that dissolve the damaging, negative, self-defeating feelings that act out through the self-destructive emotional patterns of addiction. Ms. O’Malley anticipates the products will be a trailblazer for the addiction treatment industry.
For more information about the Company and its products, please visit www.drugfreesolution.com.
About Drug Free Solution Inc.:
Drug Free Solution, Inc. (DSOL) is a wellness and lifestyle company that provides services known as the Living Breath Process®. This integrated and proprietary process, founded and pioneered by the company’s CEO Genie O’Malley, provides customers with home therapies, as well as a medical support network, that utilizes the company’s innovative three-part breath aimed at improving emotional wellness and, ultimately, quality of life. Drug Free Solution’s products – sold on www.drugfreesolution.com – focus on 49 key emotional areas, collectively named the Living Breath Process, ranging from stress, to depression, grief, anxiety, and many more. For more information on Drug Free Solution, its CEO and products, please visit www.drugfreesolution.com.
Forward Looking Statements: Statements in this document contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. These statements are based on many assumptions and estimates and are not guarantees of future performance. These statements may involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Drug Free Solution Inc. to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Drug Free Solution assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Our actual results may differ materially from the results anticipated in these forward-looking statements due to a variety of factors, including, without limitation those set forth as "Risk Factors" in our filings with the Securities and Exchange Commission ("SEC"). There may be other factors not mentioned above or included in the Company's SEC filings that may cause actual results to differ materially from those projected in any forward-looking statement The Company assumes no obligation to update any forward-looking statements as a result of new information, future events or developments, except as required by securities laws.